Jefferies Drops Coverage of Bio-Reference Labs (BRLI) After TheStreetSweeper Report

Article Stock Quotes (1) Comments (0)

Jefferies dropped coverage of Bio-Reference Labs (Nasdaq: BRLI) due to increased
business uncertainties. The firm's latest rating was "Under Review" and our last price target was $21.

"In light of increased business uncertainties, as per our Research Note dated 11/10/11 and titled "Report Puts BRLI Under High-Powered Microscope", in which we referenced an article by TheStreetSweeper, an online research organization, we do not believe we are in a position to provide a recommendation on Bio-Reference Laboratories (BRLI). As a result, we are dropping coverage of the company effective immediately."

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• Brean Capital Downgrades Tetra Tech (TTEK) to Hold

Create E-mail Alert Related Categories

Analyst Comments, Downgrades

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?